Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:576 (10 September), doi:10.1136/bmj.331.7516.576-b
| The first 150 words of the full text of this article appear below. |
EDITORThe editorial by Newland et al on preventing severe infection after splenectomy deals with the risks of malarial infection and meningitis in asplenic travellers rather cursorily.1
Asplenia, from whatever cause, is not uncommon. Worldwide travel to malarial areas is probably increasing. Increased risks of Plasmodium falciparum malaria in asplenic people, although difficult to quantify, are widely recognised. Fatal outcomes, anecdotally, are increased: I have heard of three people who acquired malaria in west Africa and died. Incidence of meningitis in sub-Saharan Africa, India, and Nepal poses substantial potential hazards.
Asplenic travellers should be advised to avoid travel to high risk malarial areas. People who travel should scrupulously adhere to measures to avoid bites and take appropriate antimalarial prophylaxis. Immediate referral for medical advice is essential should a fever develop. People travelling to areas with a high incidence of meningitis must be immunised with meningococcal ACWY vaccine (quadrivalent polysaccharide
Harald M Lipman, medical adviser, travel health clinic
Number One Health Group, London W1G 9QD haraldlipman@aol.com
Read all Rapid Responses